
CanSino Biologics Inc
SSE:688185

CanSino Biologics Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.3
73.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does CanSino Biologics Inc hold over its rivals?
What risks and challenges
does CanSino Biologics Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of CanSino Biologics Inc.
Provide an overview of the primary business activities
of CanSino Biologics Inc.
What unique competitive advantages
does CanSino Biologics Inc hold over its rivals?
What risks and challenges
does CanSino Biologics Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for CanSino Biologics Inc.
Provide P/S
for CanSino Biologics Inc.
Provide P/E
for CanSino Biologics Inc.
Provide P/OCF
for CanSino Biologics Inc.
Provide P/FCFE
for CanSino Biologics Inc.
Provide P/B
for CanSino Biologics Inc.
Provide EV/S
for CanSino Biologics Inc.
Provide EV/GP
for CanSino Biologics Inc.
Provide EV/EBITDA
for CanSino Biologics Inc.
Provide EV/EBIT
for CanSino Biologics Inc.
Provide EV/OCF
for CanSino Biologics Inc.
Provide EV/FCFF
for CanSino Biologics Inc.
Provide EV/IC
for CanSino Biologics Inc.
Show me price targets
for CanSino Biologics Inc made by professional analysts.
What are the Revenue projections
for CanSino Biologics Inc?
How accurate were the past Revenue estimates
for CanSino Biologics Inc?
What are the Net Income projections
for CanSino Biologics Inc?
How accurate were the past Net Income estimates
for CanSino Biologics Inc?
What are the EPS projections
for CanSino Biologics Inc?
How accurate were the past EPS estimates
for CanSino Biologics Inc?
What are the EBIT projections
for CanSino Biologics Inc?
How accurate were the past EBIT estimates
for CanSino Biologics Inc?
Compare the revenue forecasts
for CanSino Biologics Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of CanSino Biologics Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of CanSino Biologics Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of CanSino Biologics Inc compared to its peers.
Compare the P/E ratios
of CanSino Biologics Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing CanSino Biologics Inc with its peers.
Analyze the financial leverage
of CanSino Biologics Inc compared to its main competitors.
Show all profitability ratios
for CanSino Biologics Inc.
Provide ROE
for CanSino Biologics Inc.
Provide ROA
for CanSino Biologics Inc.
Provide ROIC
for CanSino Biologics Inc.
Provide ROCE
for CanSino Biologics Inc.
Provide Gross Margin
for CanSino Biologics Inc.
Provide Operating Margin
for CanSino Biologics Inc.
Provide Net Margin
for CanSino Biologics Inc.
Provide FCF Margin
for CanSino Biologics Inc.
Show all solvency ratios
for CanSino Biologics Inc.
Provide D/E Ratio
for CanSino Biologics Inc.
Provide D/A Ratio
for CanSino Biologics Inc.
Provide Interest Coverage Ratio
for CanSino Biologics Inc.
Provide Altman Z-Score Ratio
for CanSino Biologics Inc.
Provide Quick Ratio
for CanSino Biologics Inc.
Provide Current Ratio
for CanSino Biologics Inc.
Provide Cash Ratio
for CanSino Biologics Inc.
What is the historical Revenue growth
over the last 5 years for CanSino Biologics Inc?
What is the historical Net Income growth
over the last 5 years for CanSino Biologics Inc?
What is the current Free Cash Flow
of CanSino Biologics Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for CanSino Biologics Inc.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CN |
![]() |
CanSino Biologics Inc
SSE:688185
|
9.8B CNY | 13.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
775.3B USD | 17.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.9B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
223.1B CHF | 3.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
178B GBP | 4.3 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
197.4B CHF | 4.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
219.3B USD | 3.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
140B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CN |
![]() |
CanSino Biologics Inc
SSE:688185
|
Average P/S:
64.6
13.1
|
68%
|
0.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.2
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
3%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.1
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.8
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.3
|
7%
|
0.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.4
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.